Back

TAVI versus SAVR in intermediate-risk patients with severe aortic stenosis and chronic kidney disease: a matched comparison in a subcohort from the GARY registry

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Transcatheter aortic valve implantation: the intangibles Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Silvia Mas-Peiro

Wolfgang Goethe University, Frankfurt (Germany)

4 More presentations in this session

Presentation thumbnail
Coronary angioplasty or medical treatment in patients with aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real world analysis
Doctor R. Belo Nunes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Use of a digital application to optimize the clinical trajectory of patients in a TAVI program
Doctor M. Bellemare (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Readmission after transcatheter aortic valve implantation according to frailty
Doctor J. Strange (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Analysis of surgical bailout after transcatheter aortic valve replacement in Germany
Doctor V. Oettinger (Freiburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter aortic valve implantation: the intangibles

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
A single-centre perspective on survival and complications after transcatheter aortic valve replacement in chronic kidney disease and end-stage renal disease patients
thumbnail
Congress Presentation
Short and long-term impact of transcatheter aortic valve implantation on kidney function in patients with severe aortic stenosis
thumbnail
Congress Presentation
Impacting prognosis - Acute kidney injury post-TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources